KALA BIO, Inc. 8-K
Research Summary
AI-generated summary
KALA BIO Board Member David Lazar Resigns
What Happened
KALA BIO, Inc. (KALA) filed a Form 8-K on February 20, 2026 reporting that David Lazar notified the company of his resignation from the Board of Directors, effective February 16, 2026. The filing states Mr. Lazar’s resignation was not related to any disagreement with the company regarding its operations, policies or practices.
Key Details
- Resignation effective date: February 16, 2026.
- 8-K filing date: February 20, 2026.
- Company disclosure: Mr. Lazar’s departure “was not related to any disagreement” with the company on operations, policies or practices.
- The Form 8-K does not identify a replacement director or changes to board committees.
Why It Matters
Board changes are a governance event investors watch because directors shape oversight and strategic direction. This filing provides the basic facts — the director left and the company says there was no disagreement — but does not provide information about a successor or any change in board composition. Investors tracking KALA’s governance should note the departure and watch future filings or company announcements for any appointment or committee updates.